ImmuCell Corporation Revenue 2017–2025

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

ImmuCell Corporation annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

ImmuCell Corporation revenue for the quarter ending March 31, 2026 was 10.4 M, a 28.39% increase year-over-year.
ImmuCell Corporation revenue for the twelve months ending March 31, 2026 was 30.4 M, a 25.84% increase year-over-year.
ImmuCell Corporation annual revenue for 2025 was 27.6 M, a 4.34% increase from 2024.
ImmuCell Corporation annual revenue for 2024 was 26.5 M, a 51.64% increase from 2023.
ImmuCell Corporation annual revenue for 2023 was 17.5 M, a 5.90% decrease from 2022.
ImmuCell Corporation annual revenue for 2022 was 18.6 M.

Revenue

ANNUAL · $B

QUARTERLY · $B

YEAR-OVER-YEAR GROWTH · %

ImmuCell Corporation Revenue — FAQ

ImmuCell Corporation (ICCC) revenue over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

What is ImmuCell Corporation's revenue?

ImmuCell Corporation (ICCC) reported revenue of $28M for fiscal 2025.

Where can I see ICCC's revenue history?

The chart and table above show ImmuCell Corporation's revenue by year and by quarter, including the growth rate.